Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066

Int J Environ Res Public Health. 2022 Dec 30;20(1):630. doi: 10.3390/ijerph20010630.

Abstract

I read with interest the recent paper of Huijghebaert et al. published recently in this journal [...].

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19* / prevention & control
  • Common Cold*
  • European Union
  • Humans
  • Medical Device Legislation
  • Mutation
  • Oral Sprays
  • Public Health
  • Trypsin

Substances

  • Trypsin
  • Oral Sprays

Grants and funding

GD has received research funding from Enzymatica, who manufacture and supply the ColdZyme product.